IRONWOOD PHARMACEUTICALS INC Quarterly Nonoperating Income (Expense) in USD from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Ironwood Pharmaceuticals Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2010 to Q2 2024.
  • Ironwood Pharmaceuticals Inc Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$6.1M, a 188% decline year-over-year.
  • Ironwood Pharmaceuticals Inc Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$27.5M, a 253% decline year-over-year.
  • Ironwood Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2023 was -$2.64M, a 227% decline from 2022.
  • Ironwood Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2022 was $2.09M.
  • Ironwood Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2021 was -$31.6M, a 7.27% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$27.5M -$6.1M -$13M -188% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$14.5M -$6.06M -$11.8M -205% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$2.64M -$7.23M -$11.1M -285% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-16
Q3 2023 $8.49M -$8.09M -$9.53M -664% Jul 1, 2023 Sep 30, 2023 10-K 2024-02-16
Q2 2023 $18M $6.92M +$8.79M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $9.23M $5.76M +$7.15M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $2.09M $3.9M +$14.2M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-16
Q3 2022 -$12.2M $1.43M +$6.93M Jul 1, 2022 Sep 30, 2022 10-K 2024-02-16
Q2 2022 -$19.1M -$1.87M +$8.86M +82.6% Apr 1, 2022 Jun 30, 2022 10-K 2024-02-16
Q1 2022 -$27.9M -$1.38M +$3.66M +72.6% Jan 1, 2022 Mar 31, 2022 10-K 2024-02-16
Q4 2021 -$31.6M -$10.3M -$3.45M -50.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-16
Q3 2021 -$28.1M -$5.5M +$4.31M +43.9% Jul 1, 2021 Sep 30, 2021 10-K 2023-02-16
Q2 2021 -$32.5M -$10.7M -$3.22M -42.8% Apr 1, 2021 Jun 30, 2021 10-K 2023-02-16
Q1 2021 -$29.2M -$5.04M +$4.84M +49% Jan 1, 2021 Mar 31, 2021 10-K 2023-02-16
Q4 2020 -$34.1M -$6.88M -$5.15M -297% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-18
Q3 2020 -$28.9M -$9.8M +$35.4M +78.3% Jul 1, 2020 Sep 30, 2020 10-K 2022-02-18
Q2 2020 -$64.4M -$7.51M +$1.79M +19.2% Apr 1, 2020 Jun 30, 2020 10-K 2022-02-18
Q1 2020 -$66.2M -$9.88M -$4.97M -101% Jan 1, 2020 Mar 31, 2020 10-K 2022-02-18
Q4 2019 -$61.2M -$1.74M +$19.8M +91.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-17
Q3 2019 -$80.9M -$45.2M -$40M -761% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-17
Q2 2019 -$40.9M -$9.29M +$166K +1.76% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-17
Q1 2019 -$41.1M -$4.91M +$2.36M +32.5% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-17
Q4 2018 -$43.5M -$21.5M -$10.8M -101% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-13
Q3 2018 -$32.7M -$5.25M +$7.61M +59.2% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-13
Q2 2018 -$40.3M -$9.46M -$6.25M -194% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-13
Q1 2018 -$34M -$7.28M +$5.52M +43.1% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-13
Q4 2017 -$39.6M -$10.7M -$3.48M -48.2% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-25
Q3 2017 -$36.1M -$12.9M -$7.95M -162% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-25
Q2 2017 -$28.1M -$3.21M +$3.17M +49.7% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-25
Q1 2017 -$31.3M -$12.8M -$1.47M -12.9% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-25
Q4 2016 -$29.8M -$7.21M +$1.01M +12.2% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-22
Q3 2016 -$30.8M -$4.92M +$16.3M +76.8% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-22
Q2 2016 -$47.1M -$6.39M -$376K -6.26% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-22
Q1 2016 -$46.8M -$11.3M -$6.17M -120% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-22
Q4 2015 -$40.6M -$8.21M -$3.69M -81.6% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-22
Q3 2015 -$36.9M -$21.2M -$16M -304% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-22
Q2 2015 -$20.9M -$6.01M -$773K -14.8% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-22
Q1 2015 -$20.2M -$5.16M +$84K +1.6% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-22
Q4 2014 -$20.2M -$4.52M +$726K +13.8% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-19
Q3 2014 -$21M -$5.25M -$25K -0.48% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-19
Q2 2014 -$20.9M -$5.24M +$31K +0.59% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-19
Q1 2014 -$21M -$5.24M -$170K -3.35% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-19
Q4 2013 -$20.8M -$5.25M -$5.29M -11762% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-18
Q3 2013 -$15.5M -$5.22M -$5.25M -19448% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-18
Q2 2013 -$10.3M -$5.27M -$5.3M -17097% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-18
Q1 2013 -$4.97M -$5.07M -$5.1M -14583% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-18
Q4 2012 $138K $45K -$13K -22.4% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-07
Q3 2012 $151K $27K -$959K -97.3% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-07
Q2 2012 $1.11M $31K -$77K -71.3% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-07
Q1 2012 $1.19M $35K -$106K -75.2% Jan 1, 2012 Mar 31, 2012 10-K 2014-02-07
Q4 2011 $1.29M $58K -$1.09M -94.9% Oct 1, 2011 Dec 31, 2011 10-K 2013-02-21
Q3 2011 $2.38M $986K +$879K +821% Jul 1, 2011 Sep 30, 2011 10-K 2013-02-21
Q2 2011 $1.5M $108K -$37K -25.5% Apr 1, 2011 Jun 30, 2011 10-K 2013-02-21
Q1 2011 $1.54M $141K +$126K +840% Jan 1, 2011 Mar 31, 2011 10-K 2013-02-21
Q4 2010 $1.41M $1.14M Oct 1, 2010 Dec 31, 2010 10-K 2012-02-29
Q3 2010 $107K Jul 1, 2010 Sep 30, 2010 10-K 2012-02-29
Q2 2010 $145K Apr 1, 2010 Jun 30, 2010 10-K 2012-02-29
Q1 2010 $15K Jan 1, 2010 Mar 31, 2010 10-K 2012-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.